| P/E (FY) | — | Sales (TTM) | $151.8M |
| Earnings (TTM) | -$11.2M | ROE | −14.07% |
| Net Margin | −7.68% | ROIC | −6.64% |
| Debt / Equity | 0.64 | TD / EBITDA | 45.90 |
| EPS Growth 3Y | — | Sales Growth 3Y | −3.47% |
| Market Cap | $328.7M | Trading Days | 1184 |
| 52W High | 12.00 |
| 52W Low | 1.51 |
| % Off High | −61.17% |
| YTD | 135.35% | 1Y | −26.50% |
| 3Y | −46.74% | Since incept. (ann.) | −21.17% |
Reportable 100%
| Ann. Volatility (1Y) | 118.18% | Ann. Volatility (3Y) | 96.77% |
| Sharpe (1Y) | 0.33 | Sharpe (3Y) | 0.27 |
| Max Drawdown (1Y) | −86.44% | Max Drawdown (3Y) | −86.44% |
| Beta (3Y, vs SPY) | 2.70 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| SBC | SBC Medical Group Holdings Inc | $330.1M | 6.4 |
| TOI | Oncology Institute, Inc. | $494.9M | — |
| LFMD | LifeMD, Inc. | $185.7M | 15.4 |
| TDOC | Teladoc Health, Inc. | $1.69B | — |
| HIMS | Hims & Hers Health, Inc. | $7.57B | 57.5 |
| HLYK | HealthLynked Corp | $9.0M | — |
| CCM | Concord Medical Services Holdings Ltd | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $328.9M | — |
| CATX | Perspective Therapeutics, Inc. | $327.3M | — |
| CTNM | Contineum Therapeutics, Inc. | $327.1M | — |
| ELMD | Electromed, Inc. | $326.9M |
| 46.4 |
| CV | CapsoVision, Inc | $330.8M | — |
